NO20010569D0 - Proteaseinhibitorer for anvendelse ved behandling av psoriasis - Google Patents

Proteaseinhibitorer for anvendelse ved behandling av psoriasis

Info

Publication number
NO20010569D0
NO20010569D0 NO20010569A NO20010569A NO20010569D0 NO 20010569 D0 NO20010569 D0 NO 20010569D0 NO 20010569 A NO20010569 A NO 20010569A NO 20010569 A NO20010569 A NO 20010569A NO 20010569 D0 NO20010569 D0 NO 20010569D0
Authority
NO
Norway
Prior art keywords
psoriasis
treatment
protease inhibitors
protease
inhibitors
Prior art date
Application number
NO20010569A
Other languages
English (en)
Other versions
NO20010569L (no
Inventor
Clive Leighton Bunn
Phillip John Sharp
Original Assignee
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd filed Critical Biotech Australia Pty Ltd
Publication of NO20010569D0 publication Critical patent/NO20010569D0/no
Publication of NO20010569L publication Critical patent/NO20010569L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010569A 1998-08-05 2001-02-02 Proteaseinhibitorer for anvendelse ved behandling av psoriasis NO20010569L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP5087A AUPP508798A0 (en) 1998-08-05 1998-08-05 Method of treating psoriasis
PCT/IB1999/001483 WO2000007620A1 (en) 1998-08-05 1999-08-05 Protease inhibitors for use in the treatment of psoriasis

Publications (2)

Publication Number Publication Date
NO20010569D0 true NO20010569D0 (no) 2001-02-02
NO20010569L NO20010569L (no) 2001-04-04

Family

ID=3809320

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010569A NO20010569L (no) 1998-08-05 2001-02-02 Proteaseinhibitorer for anvendelse ved behandling av psoriasis

Country Status (10)

Country Link
US (1) US6288025B1 (no)
EP (1) EP1102599A4 (no)
JP (1) JP2002522396A (no)
KR (1) KR20010072278A (no)
CN (1) CN1322138A (no)
AU (1) AUPP508798A0 (no)
CA (1) CA2339485A1 (no)
IL (1) IL141056A0 (no)
NO (1) NO20010569L (no)
WO (1) WO2000007620A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ380699A0 (en) * 1999-11-02 1999-11-25 Biotech Australia Pty Limited Protease inhibitors as modulators of periodontal wound healing
JP2006508971A (ja) * 2002-11-20 2006-03-16 アライバ−プロメティック インコーポレイティド プロテアーゼ阻害剤を使用して炎症性疾患を治療する組成物及び方法
SE531785C2 (sv) * 2006-12-05 2009-08-04 Bengt-Sture Ershag Anläggning för återvinning av kol och kolväteföreningar genom pyrolys
WO2009026949A1 (en) * 2007-08-31 2009-03-05 Dsm Ip Assets B.V. 4-amidino benzylamines for cosmetic and/or dermatological use
WO2009093119A2 (en) * 2008-01-21 2009-07-30 Med Discovery S.A. Use of serine protease inhibitors in the treatment of skin diseases
US10377818B2 (en) 2015-01-30 2019-08-13 The Board Of Trustees Of The Leland Stanford Junior University Method of treating glioma

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290762A (en) * 1986-12-24 1994-03-01 John Lezdey Treatment of inflammation
DE3829523A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression
EP1029921B1 (en) 1989-03-06 2002-10-23 The Board of Regents of The University of Texas System Serpin resistant t-PA; mutants; genes
US5550042A (en) 1989-03-06 1996-08-27 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
US5304482A (en) 1989-03-06 1994-04-19 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors
ZA905737B (en) 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
KR920701436A (ko) 1989-09-05 1992-08-11 피터 터베이 재조합 생성물
US5204807A (en) 1989-10-04 1993-04-20 Pitney Bowes Plc. Postage meter housing arrangement having RF and electromagnetic induction shielding
ES2106772T3 (es) 1989-12-20 1997-11-16 Biotech Australia Pty Ltd Variantes de pai-2.
US5242801A (en) 1990-08-06 1993-09-07 University Of Iowa Research Foundation Diagnosing malignant hyperthermia susceptibility by detection of abnormal proteolytic enzyme digestion fragments of the ryanodine receptor
JPH06279316A (ja) 1993-03-25 1994-10-04 Shiseido Co Ltd 皮膚外用剤
US5403482A (en) 1993-10-12 1995-04-04 Gelman Sciences Inc. Self-supporting, pleated, spirally wound filter and the corresponding process of making
GB9323165D0 (en) * 1993-11-10 1994-01-05 Chiros Ltd Compounds
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US5939525A (en) * 1995-03-27 1999-08-17 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
WO1999049887A1 (en) 1998-04-01 1999-10-07 Biotech Australia Pty. Limited Use of protease inhibitors for treating skin wounds

Also Published As

Publication number Publication date
CN1322138A (zh) 2001-11-14
AUPP508798A0 (en) 1998-08-27
WO2000007620A1 (en) 2000-02-17
NO20010569L (no) 2001-04-04
KR20010072278A (ko) 2001-07-31
IL141056A0 (en) 2002-02-10
EP1102599A4 (en) 2004-03-17
US6288025B1 (en) 2001-09-11
CA2339485A1 (en) 2000-02-17
JP2002522396A (ja) 2002-07-23
EP1102599A1 (en) 2001-05-30

Similar Documents

Publication Publication Date Title
ATE371457T1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DE69910368D1 (de) Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen
NO985652D0 (no) Anvendelse av naaladaseinhibitorer ved behandling av kreft
NO995095D0 (no) Substituerte imidazoler nyttig ved behandlingen av inflammasjonssykdommer
EE200200461A (et) Pteridiiniühendid psoriaasi raviks
NO20015112D0 (no) Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
ID30339A (id) Metode pengobatan baru
DE60136477D1 (de) Retinoide zur behandlung von emphysem
PT1206436E (pt) Retinoides para o tratamento de enfisema
DE60011822D1 (de) Verbesserung beim Positionieren von Schleifscheiben
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
NO991619L (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
FI964342A (fi) Halogeenimetyyliamideja IL-1beta-proteaasi-inhibiittoreina
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
SI1197485T1 (en) Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
GB9816234D0 (en) Compounds for use in the treatment of inflammation
NO20004920D0 (no) Anvendelse av proteaseinhibitorer for behandling av hudskader
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
NO20024236D0 (no) Behandling av psoriasis
DK0904070T3 (da) Anvendelse af buckminsterfulleren til behandling af neurotoksiske læsioner
NO991146L (no) FremgangsmÕte ved overflatebehandling
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application